TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
BBIO

BridgeBio Pharma Inc

Healthcare · Biotechnology

66.60$ +0.0% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

BridgeBio Pharma Inc (BBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,217 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BBIO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
655 546 849 794 665 919 882 1,080 998 936 1,371 1,217
588 478 783 616 445 721 695 912 839 754 1,178 1,093
505 376 475 547 266 681 541 749 643 570 880 678
543 435 520 587 266 681 541 757 646 587 940 720
5.2 1.8 235 0.7 0.5 4.7 115 77 117 139 205 254
17 17 -28 0.0 4.0 18 25 27 33 53
27 26 26 25 25 24 28 30 29 28 27 27
1,849 1,889 1,886 1,876 1,883 2,377 2,520 2,859 2,921 3,013 3,640 3,723
106 144 141 134 139 154 152 176 217 288 816 891
4.1 4.1 4.5 4.6 4.6 4.5 5.2 14 5.3 17 573 551
4.5 11 4.7 18 13 9.6 28 26 19 36 29 27
1,721 1,727 1,716 1,718 1,719 1,721 1,848 1,850 1,851 1,852 1,926 1,928
-1,208 -1,354 -1,050 -1,093 -1,230 -1,468 -1,648 -1,788 -1,933 -2,077 -2,269 -2,515
-2,392 -2,561 -2,596 -2,669 -2,831 -3,096 -3,264 -3,446 -3,628 -3,821 -3,985 -4,137
163 174 179 188 189 189 190 191 191 197 195 196

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?